Рынок стартапов
← Все стартапы
Kiwi Biosciences

Kiwi Biosciences

YCS21

Patent-pending enzymes to break down common dietary triggers

/ 100
О компании

Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.

Команда
10 чел.
Статус
Active